Skip to content

Other psychedelics

James Linden, Daniel Robin

Psychedelics as Psychiatric Medications March 1, 2023 Peer reviewed DOI: 10.1093/med/9780192863607.003.0008

Summary

The chapter discusses lesser-known psychedelics that may have significant medicinal potential despite being less understood and having limited clinical data. It highlights that while many psychedelics have established psychopharmacology, these lesser-known substances exhibit novel effects that are not yet fully explained. The exploration aims to shed light on five of these compounds, emphasizing the need for further research in psychedelic science.

Study at a glance

Key finding There is a growing interest in understanding the potential of lesser-known psychedelics, which currently lack substantial clinical data.

Abstract

Abstract This chapter will detail some of the lesser-known psychedelics. While lesser known, some of these are arguably the most potent molecules, and one could argue these hold the most potential for medicine. We will go on a small journey into a lesser-understood corner of plant medicine and psychedelics. Many of the psychedelics discussed so far in this publication have well-elucidated and reasonably well-developed psychopharmacology. The lesser knowns are similarly less understood and have novel effects, the causes of which are still essentially baffling. In the great pursuit of psychedelic science there has been an increased interest to understand the potential of these lesser knowns, which will be overviewed here. There are also significantly fewer clinical data available for these, in fact, none in some cases, at least not of huge or encouraging impact to humanity thus far. It gives great pleasure to present five lesser knowns.

Comments

No comments yet.

Log in to comment